EichorEICHOR
Condition: Inflammatory Cytokines Synced from ClinicalTrials.gov · August 07, 2026

Recruiting studies: Inflammatory Cytokines

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Natural History Study of the KSHV Inflammatory Cytokine Syndrome (KICS)
Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT01419561Effect of Aronia Berry Consumption on Inflammatory Parameters
NA · 1 location(s) · Amasya University · NCT06702696Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma
Phase 2 · 17 location(s) · SCRI Development Innovations, LLC · NCT05972135Efficacy and Safety of Cytokine Adsorption and Plasma Exchange in Patients With ACLF and Sepsis
NA · 1 location(s) · Third Affiliated Hospital, Sun Yat-Sen University · NCT06562803Antisecretory Factor In Severe Traumatic Brain Injury
Phase 2 · 1 location(s) · Peter Siesjö · NCT04117672Monocyte Profiles in Critically Ill Patients With Pseudomonas Aeruginosa Sepsis
Phase N/A · 1 location(s) · University of Ulm · NCT03044223Biomarkers in Autoimmune Diseases, Vasculitis and Auto Inflammatory Diseases
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT05383339Prevalence of Antibodies and Cytokines in Participants With Chronic Granulomatous Disease
Phase N/A · 52 location(s) · Ensoma · NCT06605378Study of Cytokine Release Syndrome Prophylaxis and Treatment With Siltuximab Prior to Epcoritamab
Phase 1 · 1 location(s) · Taylor Brooks · NCT06447376An Artificial Intelligence-based Approach in Total Knee Arthroplasty: From Inflammatory Responses to Personalized Medici
NA · 1 location(s) · Fondazione Policlinico Universitario Campus Bio-Medico · NCT06634654Inflammatory Challenge in Human Aggression.
Phase 2 · 1 location(s) · Ohio State University · NCT06665074The Role of Cytokines and Regulatory T Lymphocytes in Migraine Pathophysiology.
NA · 1 location(s) · University Hospital, Clermont-Ferrand · NCT06426316Effect of Salovum® on Pressure, Oxygen and Inflammation in Glioblastoma
Phase 2 · 1 location(s) · Peter Siesjö · NCT07364786A Phase II Study of Siltuximab for CRS/ICANs After CAR-T in Multiple Myeloma
Phase 2 · 1 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT07106671Dietary Interventions in Cancer Patients Treated With Immune Checkpoint Inhibitors
NA · 1 location(s) · University of Pittsburgh · NCT06475807ENVIEANCILLAIRE: Efficacy of Nirsevimab in Children Hospitalised With RSV Bronchiolitis - A Subsidiary Study on the Immu
Phase N/A · 3 location(s) · Centre Hospitalier Intercommunal Creteil · NCT07698769Cytokine Response to Abdominal Wall Reconstruction
Phase N/A · 1 location(s) · Northwestern University · NCT07422584Effect of Lidocaine-Dexmedetomidine on Pain, Inflammation, and Oxidative Stress After Bariatric Surgery.
Phase 4 · 2 location(s) · Instituto Mexicano del Seguro Social · NCT07073846Curcumin to Improve Inflammation and Symptoms in Patients With Clonal Cytopenia of Undetermined Significance, Low Risk M
Phase 2 · 2 location(s) · University of Southern California · NCT06063486Early Detection of Complications During Immunotherapy for Haematological Malignancy
NA · 1 location(s) · Rigshospitalet, Denmark · NCT06377059Focused Ultrasound Spleen Stimulation and Inflammation in Septic Shock
NA · 1 location(s) · First Affiliated Hospital of Wannan Medical College · NCT06990295Hemophagocytic Lymphohistiocytosis (HLH) Evaluation and Research of Clinical, ImmUnoLogic and TranscriptomE Study
Phase N/A · 2 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT06339177Adjunctive Methylene Blue for Immunotherapy-related CRS and ICANS: Phase I Study
Phase 1 · 1 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT07169487Periodontitis and Inflammation
Phase N/A · 2 location(s) · Assistance Publique - Hôpitaux de Paris · NCT04831060NexCAR19 (Talikabtagene Autoleucel) in Relapsed/Refractory B-Cell Malignancies (NexCAR19)
Phase 2/Phase 3 · 4 location(s) · Health Institutes of Turkey · NCT07502118Tadekinig Alfa (IL-18BP) Rescue Therapy for CAR T Cell Related Cytokine Release Syndrome (CRS) and HLH-like Syndrome
EARLY_Phase 1 · 1 location(s) · University of Pennsylvania · NCT05306080Xanthohumol as an Adjuvant in the Treatment of Septic Shock
Phase 2 · 1 location(s) · Medical University of Lublin · NCT06225258The Effectiveness of Nano Bio Fusion Gingival Gel (NBF) on Wound Healing at the Palate (Donor Site) After Soft Tissue Gr
NA · 1 location(s) · King Abdullah University Hospital · NCT07330154CytOSorb TreatMent Of Critically Ill PatientS Registry
Phase N/A · 28 location(s) · CytoSorbents, Inc · NCT05146336Molecular Signatures in Inflammatory Skin Disease
Phase N/A · 1 location(s) · Prof. Dr. Stephan Weidinger · NCT03358693
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.